You are here:
Supplement Manufacturing — Pharmaceutical Grade
Last Updated:February 28, 2026
About This Investor
JP-B-201
With roots in Japan, they are currently screening targets across Indonesia, Malaysia, India. Sales of over 1 billion yen Stable operating profit Minority investment desired. Key target profile: Pharmaceutical (supplement) manufacturing and sales. The primary M&A purpose is Expand existing businesses overseas. Budget guidance is $6.54M – $13.1M. Reach out to us to share a…
Pharmaceutical Manufacturing (Supplements)
India, Indonesia, Malaysia
Overseas Expansion
$6.54M - $13.1M
Minority preferred | Revenue ≥ USD 6.5M | Stable op profit
Request Full Investor Profile
Similar Investors
JP-B-545
Their focus is: Marine transportation, port transportation, land transportation, warehousing/non
Marine Logistics
ASEAN, Vietnam
Strategic Expansion
$654K - $9.81M
Minority possible | Majority preferred
JP-B-404
Indicative ticket size is $654K – $1.96M, depending on fit
EdTech
Cambodia, Indonesia, Malaysia, Vietnam
Overseas Expansion
$654K - $1.96M
Minority / Majority
JP-B-44
Priority theme: General contractors Projects with developers can be considered.
Construction
ASEAN, India
Strategic Expansion
$654K - $65.4M
Minority / Majority